Expectorant Drugs Market will reach US$ 38,455.4 Million by 2034, rising at a 4.3% CAGR: Future Market Insights, Inc.
Ongoing research and development in the pharmaceutical industry are poised to enhance expectorant drugs, potentially leading to the creation of more potent formulations and advanced delivery systems. This innovation may fuel significant growth in the Expectorant Drugs market by offering improved therapeutic options.
NEWARK, Del, Dec. 04, 2023 (GLOBE NEWSWIRE) -- In 2024, the expectorant drugs market is projected to produce US$ 17,648.2 million. Forecasts state that in 2034, the market will be valued US$ 38,455.4 million. The market is anticipated to grow at a CAGR of 4.3% between 2024 and 2034. The common cold, pneumonia, and bronchitis are examples of respiratory ailments that could raise the need for expectorants. Expectorants, which reduce excessive mucus production and congestion, may aid patients with these disorders by improving respiratory function and symptom relief.
An increasing number of dry cough cases resulting in dry throats drives the demand for expectorant drugs in the market. With FDA approvals granted, expectorants are making significant progress on the global market. Throughout the healthcare industry, the FDA regulates and approves expectorant drugs to ensure their safety, effectiveness, and quality.
Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18502
The prevalence of coughs is expected to increase significantly, leading to increased demand for expectorant drugs. For instance, according to data released by the National Center for Biotechnology Information, cough accounted for about 8% of all consultations with primary care physicians worldwide. According to the same source, the annual incidence of cough in the general population is projected to be between 10% and 33% globally. Due to changes in dietary habits among youth and middle-class consumers, cough cases are also on the rise globally.
Key Takeaways:
- Secretion enhancers are the leading segment as drug type and held approximately 59.7% market value share in 2024.
- By product type, over-the-counter (OTC) drugs are expected to expand at a CAGR of 8.4%.
- The United States is expected to be an opportunistic market, registering a 6.8% CAGR through 2034.
- Germany to experience a CAGR of 4.5% with respect to expectorant drug sales.
- India and China to register CAGRs of 7.2% and 8.1% respectively from 2024 to 2034.
“Rising prevalence of cold and cough, coupled with expanding product launches, is expected to drive sales of expectorant drugs across the globe. Rising research and development activities and regulatory approvals will increase in the next few years,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI).
Market Competition
Manufacturers are turning to discreet and innovative expectorant drugs to meet consumer demands. Therefore, brand promotion takes place on a parallel path. The major key players mostly rely on organic and inorganic growth strategies such as product launches, acquisitions, and collaborations. Some of the key developments are as follows:
Key Developments:
- In August 2023, Marksans Pharma secured approval from the US Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg (OTC). Guaifenesin extended-release tablets remove mucus from the bronchial passageways and improve coughing by loosening mucus and thinning bronchial secretions.
- In November 2022, During the flu season of 2022, a clean medicine company Genexa, the first to remove all artificially derived inactive ingredients from its products, announced the adult-only cough suppressant and expectorant Cough and chest Congestion that temporarily controls coughs, relieves chest congestion, and thins and loosens mucus with its maximum strength cough suppressant and expectorant.
Expectorant Drugs Market Size:
| Attributes | Details | |
| Estimated Market Size in 2024 | US$ 17,648.2 million | |
| Projected Market Valuation in 2034 | US$ 38,455.4 million | |
| Value-based CAGR 2024 to 2034 | 4.3 | % |
| Forecast Period | 2024 to 2034 | |
| Historical Data Available for | 2019 to 2023 | |
| Market Analysis | Value in US$ million | |
| Key Regions Covered |
|
|
| Key Market Segments Covered |
|
|
| Key Countries Profiled |
|
|
| Key Companies Profiled |
|
|
Unlock Insights & Discounts Now! Click to Gain Your Edge: https://www.futuremarketinsights.com/checkout/18502
Key Segments:
By Drug Type:
- Secretion Enhancer
- Potassium Citrate
- Potassium Iodide
- Sodium Citrate
- Guaiphenesin
- Ammonium Chloride
- Others
- Mucolytics
- Bromhexine
- Ambroxol
- Acetyl Cysteine
- Carbocisteineurine
By Dosage Form:
- Oral Solid
- Powder & Granules
- Tablet
- Capsule
- Lozenge
- Oral Liquid
- Syrup
- Solution
- Suspension
- Elixir
- Inhalant
By Product Type:
- Over-The-Counter (OTC)
- Prescription Drug
By Distribution Channel:
- Hospital Pharmacies
- Retail Store
- Drug Store
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:
Rx-to-OTC Switches Market Outlook: The market is estimated to capture a valuation of US$ 38.7 billion in 2023 and is projected to reach US$ 66.5 billion by 2033.
Over-The-Counter (OTC) Veterinary Drugs Market Forecast: The market is expected to expand its roots at a steady CAGR of 7.9% during the forecast period.
Cold, Cough, and Sore Throat Remedies Market Trends: The global market is expected to enjoy a valuation of US$ 39.9 Billion by the end of the year 2022, and further expand at a CAGR of 0.6% between 2022 and 2032, reaching a valuation of US$ 37.7 Billion by 2032.
Over-The-Counter Pain Medication Market Growth: Global consumption market currently accounts for a revenue of US$ 21.8 Billion in 2022, and is estimated to attain a valuation of US$ 27.7 Billion by the end of 2028.
Pharmaceuticals Excipients Market Revenue: The market is expected to register a CAGR of 6% during the forecast period, up from US$ 7.9 Billion in 2021 to reach a valuation of US$ 10.9 Billion by 2026.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
